Steven Wager
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 10%
- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
- Electroconvulsive Therapy Studies
Papers in
-
- Treatment of Major Depression 6
-
- Neurotransmitter Receptor Influence on Behavior 3
- Co-authors
- Frederic M. Quitkin (8 shared papers)Edward V. Nunes (5 shared papers)Jonathan W. Stewart (6 shared papers)Patrick J. McGrath (6 shared papers)Wilma Harrison (6 shared papers)Donald F. Klein (3 shared papers)Patrick J. McGrath (2 shared papers)Katja Ocepek‐Welikson (4 shared papers)
- Journals
- Journal of Clinical Psychopharmacology (3 papers)Biological Psychiatry (1 paper)American Journal of Psychiatry (1 paper)Psychiatry Research (1 paper)Human Psychopharmacology Clinical and Experimental (1 paper)
- Partner nations
- United StatesArmenia
In The Last Decade
Steven Wager
10 papers receiving 297 citations
Peers
Comparison fields: 5 of 41
- Biological Psychiatry 36
- Psychiatry and Mental health 115
- Pharmacology 134
- Behavioral Neuroscience 18
- Cellular and Molecular Neuroscience 81
Countries citing papers authored by Steven Wager
This map shows the geographic impact of Steven Wager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Wager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Wager more than expected).
Fields of papers citing papers by Steven Wager
This network shows the impact of papers produced by Steven Wager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Wager. The network helps show where Steven Wager may publish in the future.
Co-authors
The 18 scholars most cited alongside Steven Wager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 76 | |
| 2 | 1992 | 50 | |
| 3 | 1990 | 49 | |
| 4 | A placebo-controlled trial of L-deprenyl in atypical depression. | 1989 | 35 |
| 5 | 1990 | 30 | |
| 6 | Phenelzine treatment of melancholia. | 1986 | 29 |
| 7 | 1994 | 18 | |
| 8 | 1993 | 16 | |
| 9 | 1990 | 12 | |
| 10 | 1988 | 1 |
About Steven Wager
Steven Wager is a scholar working on Pharmacology, Cellular and Molecular Neuroscience, Psychiatry and Mental health, Molecular Biology and Biological Psychiatry, having authored 10 papers that have together received 316 indexed citations. Recurring topics across this work include Treatment of Major Depression (6 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Tryptophan and brain disorders (2 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers), Schizophrenia research and treatment (2 papers), Electroconvulsive Therapy Studies (2 papers), Nicotinic Acetylcholine Receptors Study (2 papers) and Memory and Neural Mechanisms (1 paper). The work is most often cited by research in Biological Psychiatry (36 citations), Psychiatry and Mental health (115 citations), Pharmacology (134 citations), Behavioral Neuroscience (18 citations) and Cellular and Molecular Neuroscience (81 citations). Steven Wager has collaborated with scholars based in United States and Armenia. Frequent co-authors include Frederic M. Quitkin, Edward V. Nunes, Jonathan W. Stewart, Patrick J. McGrath, Wilma Harrison, Donald F. Klein, Patrick J. McGrath, Katja Ocepek‐Welikson, F M Quitkin and E Tricamo. Their work appears in journals such as Journal of Clinical Psychopharmacology, Biological Psychiatry, American Journal of Psychiatry, Psychiatry Research and Human Psychopharmacology Clinical and Experimental.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.